Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Ruggiero

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Dermatology Reports|February 6, 2026
Linear IgA bullous dermatosis in a 4-year-old childFilomena Barbato, Gaetano Licata, Eugenia Veronica Di Brizzi, et al.
The American Journal of Gastroenterology|October 3, 2002
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remissionRosa Zampino, Aldo Marrone, Peter Karayiannis, et al.
Journal of Clinical Gastroenterology|October 20, 2004
Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcomeEmanuele Durante-Mangoni, Patrizia Iardino, Marianna Resse, et al.
Pharmaceutics|April 26, 2025
Topical Administration of Vitamin D2 Combined with Colloidal Silver Nanoparticles Promotes Wound Repair and Protection Against Skin Irritation and UVB Irradiation in 3D Reconstructed Human Skin ModelsFrancesca Truzzi, Camilla Tibaldi, Silvia Dilloo, et al.
Le Infezioni in Medicina|October 13, 2005
Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assaysRosa Zampino, Aldo Marrone, Niklas Finnström, et al.
Journal of Medical Virology|March 26, 2004
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatmentRosa Zampino, Aldo Marrone, Emanuele Durante Mangoni, et al.
Journal of Hepatology|September 20, 2005
Hepatic steatosis and insulin resistance: does etiology make a difference?Amedeo Lonardo, Silvia Lombardini, Federica Scaglioni, et al.
Internal and Emergency Medicine|August 4, 2009
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferonLuigi E Adinolfi, Emanuele Durante-Mangoni, Marta Salzillo, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 18, 2009
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosisAmedeo Lonardo, Stefano Ballestri, Luigi E Adinolfi, et al.
Le Infezioni in Medicina|December 25, 2016
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot studyGiuseppe Ruggiero, Aldo Marrone, Ilaria Rainone, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Dermatology Reports|February 6, 2026
Linear IgA bullous dermatosis in a 4-year-old childFilomena Barbato, Gaetano Licata, Eugenia Veronica Di Brizzi, et al.
The American Journal of Gastroenterology|October 3, 2002
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remissionRosa Zampino, Aldo Marrone, Peter Karayiannis, et al.
Journal of Clinical Gastroenterology|October 20, 2004
Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcomeEmanuele Durante-Mangoni, Patrizia Iardino, Marianna Resse, et al.
Pharmaceutics|April 26, 2025
Topical Administration of Vitamin D2 Combined with Colloidal Silver Nanoparticles Promotes Wound Repair and Protection Against Skin Irritation and UVB Irradiation in 3D Reconstructed Human Skin ModelsFrancesca Truzzi, Camilla Tibaldi, Silvia Dilloo, et al.
Le Infezioni in Medicina|October 13, 2005
Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assaysRosa Zampino, Aldo Marrone, Niklas Finnström, et al.
Journal of Medical Virology|March 26, 2004
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatmentRosa Zampino, Aldo Marrone, Emanuele Durante Mangoni, et al.
Journal of Hepatology|September 20, 2005
Hepatic steatosis and insulin resistance: does etiology make a difference?Amedeo Lonardo, Silvia Lombardini, Federica Scaglioni, et al.
Internal and Emergency Medicine|August 4, 2009
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferonLuigi E Adinolfi, Emanuele Durante-Mangoni, Marta Salzillo, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 18, 2009
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosisAmedeo Lonardo, Stefano Ballestri, Luigi E Adinolfi, et al.
Le Infezioni in Medicina|December 25, 2016
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot studyGiuseppe Ruggiero, Aldo Marrone, Ilaria Rainone, et al.
Pageof 6